Tidal Investments LLC boosted its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 9.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,595,264 shares of the company’s stock after acquiring an additional 889,086 shares during the quarter. Tidal Investments LLC owned approximately 1.13% of Tilray worth $14,092,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Lido Advisors LLC bought a new position in Tilray during the fourth quarter valued at approximately $28,000. Verdence Capital Advisors LLC bought a new position in Tilray during the fourth quarter valued at approximately $29,000. Dudley Capital Management LLC bought a new position in Tilray during the fourth quarter valued at approximately $29,000. Ameritas Advisory Services LLC bought a new position in Tilray during the fourth quarter valued at approximately $32,000. Finally, Newman Dignan & Sheerar Inc. raised its position in Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock valued at $35,000 after acquiring an additional 10,000 shares in the last quarter. Institutional investors own 9.35% of the company’s stock.
Analysts Set New Price Targets
TLRY has been the topic of several recent research reports. Roth Capital reaffirmed a “neutral” rating on shares of Tilray in a research report on Monday, April 14th. Piper Sandler lowered their price target on Tilray from $2.00 to $1.00 and set a “neutral” rating on the stock in a report on Wednesday, April 9th.
Tilray Trading Up 12.5%
Shares of TLRY stock opened at $0.50 on Monday. Tilray Inc has a 12 month low of $0.41 and a 12 month high of $2.15. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The business’s 50 day moving average is $0.53 and its two-hundred day moving average is $0.96. The company has a market cap of $498.22 million, a PE ratio of -1.65 and a beta of 1.95.
Tilray (NASDAQ:TLRY – Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company had revenue of $185.78 million for the quarter, compared to analyst estimates of $213.38 million. Equities analysts predict that Tilray Inc will post -0.2 EPS for the current year.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
- Five stocks we like better than Tilray
- What does consumer price index measure?
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- Transportation Stocks Investing
- Savvy Investors Are Raising a Glass for Heineken Stock
- How to trade penny stocks: A step-by-step guide
- Top 4 ETFs for China Exposure After Tariff Relief
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.